Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC ...

Preservation of Skeletal Muscle Function Shown Over 3 Years Resulting in 52% Slowing of Disease----Data Presented at the 2025 Muscular ...

Wearable and implantable biosensors that can accurately detect biological molecules in a non- or minimally invasive manner ...

Post-COVID pulmonary fibrosis, which involves scarring of the lungs that can worsen over time and may require a lung ...

Insilico Medicine has raised $110 million in Series E funding for its artificial intelligence-powered drug discovery ...

announces the filing of a new patent application directed to the use of Thykamine™ as an antifibrotic agent. Backed by in vivo data, the patent application displays the potential effectiveness of ...

announces the filing of a new patent application directed to the use of Thykamine™ as an antifibrotic agent. Backed by in vivo data, the patent application displays the potential effectiveness ...

Apollo Hospitals successfully hosted ASPIRE 2025 (Apollo Symposium on Pulmonary Interventions and Respiratory Excellence) in ...

Promising Nonalcoholic Steatohepatitis Therapies such as AZD2693, Saroglitazar Magnesium 4 mg, Semaglutide (SEMA), Cilofexor ...

Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, recently announced that its breakthrough drug candidate for idiopathic pulmonary ...

Explore SGMT's breakthrough MASH therapy, Denifanstat, with FDA designation & Phase 3 progress. Click here to read my most ...

The FDA has granted Priority Review to the BLA for deramiocel (CAP-1002) for the treatment of Duchenne muscular dystrophy cardiomyopathy.